Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of lncRNA-RP11-290F20.3 and small interfering RNA of lncRNA-RP11-290F20.3

A small interference, gastric cancer technology, applied in the field of biomedicine, can solve the problems of incomplete clear pathogenesis of gastric cancer, unsatisfactory results in the prevention, diagnosis and treatment of gastric cancer, etc. Effect

Inactive Publication Date: 2017-12-01
QINGDAO UNIV
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of gastric cancer is not completely clear, and the prevention, diagnosis and treatment of gastric cancer have not yet achieved satisfactory results. It is urgent to develop new technologies and methods for the diagnosis, prevention and treatment of gastric cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of lncRNA-RP11-290F20.3 and small interfering RNA of lncRNA-RP11-290F20.3
  • Applications of lncRNA-RP11-290F20.3 and small interfering RNA of lncRNA-RP11-290F20.3
  • Applications of lncRNA-RP11-290F20.3 and small interfering RNA of lncRNA-RP11-290F20.3

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Detection of lncRNA-RP11-290F20.3 expression in clinical gastric cancer tissues and gastric cancer cell lines

[0066] In this example, the clinical gastric cancer tissues and their paracancerous tissues used were freshly isolated tumor tissues from Qingdao Cancer Hospital, which were cut into small tissue pieces and frozen at -80°C for later use.

[0067] In this example, the normal gastric mucosal epithelial cells and gastric cancer cell lines used were cultured and frozen under normal normal culture conditions in the laboratory.

[0068] The total RNA of gastric cancer and adjacent tissues was extracted by Trizol reagent, and the expression level of lncRNA-RP11-290F20.3 was detected by real-time fluorescent quantitative PCR.

[0069] lncRNA-RP11-290F20.3 was amplified by PCR, and the amplified nucleotide sequence was 539bp in full length, and the sequence was shown in SEQID No.2.

[0070] The PCR reaction system is calculated as 50 μL,

[0071] The PCR conditions a...

Embodiment 2

[0097] Small interfering RNA of lncRNA-RP11-290F20.3 inhibits the proliferation of gastric cancer cells

[0098] In this example, the sequence in the small interfering RNA synthesized against lncRNA-RP11-290F20.3 is

[0099] 5'-GGAGAAUAAACCCUCGGAU-3' (SEQ ID NO. 1). The transfection treatment was carried out by lipofectamine2000, and a blank group, a control group and a small interfering RNA experimental group were respectively set up. The transfection operation was carried out according to the operating instructions of the kit, and the liposome lipofectamine2000 was purchased from Invitrogen;

[0100] The EdU solution in this example was purchased from Guangzhou Ruibo;

[0101] The cell fixative in this embodiment is the PBS buffer containing 4% paraformaldehyde;

[0102] The osmotic agent in this embodiment is the PBS buffer solution of 0.5% TritonX-100;

[0103] Using the gastric cancer cell line BGC823 in Example 1 as a cell model, the gastric cancer cell line BGC823 (...

Embodiment 3

[0108] Small interfering RNA of lncRNA-RP11-290F20.3 inhibits the invasion and migration of gastric cancer cells

[0109] The gastric cancer cell line BGC823 treated with the small interfering RNA of lncRNA-RP11-290F20.3 in Example 2 was used as a cell model. The invasion ability of cells was detected by Transwell method, and the specific operation was as follows:

[0110] Coat the upper surface of the bottom membrane of the Transwell chamber with 50 mg / L Matrigel 1:10 dilution, and incubate at 37°C; digest the cells 12 hours after the small interfering RNA of lncRNA-RP11-290F20.3 is treated, and use PBS and serum-free The culture medium was washed once successively, the cells were suspended with serum-free medium, counted, and the concentration was adjusted to 3×10 5 / mL; add 600-800 μL medium containing 20% ​​serum to the lower chamber of the Transwell (i.e. the bottom of the 24-well plate), add 100-150 μL cell suspension to the upper chamber, and continue to culture in the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides the use of a long-chain non-coding RNA lncRNA-RP11-290F20.3 in the preparation of a kit for diagnosis and / or prognosis evaluation of gastric cancer, and the small interference of the lncRNA-RP11-290F20.3 Use of RNA in the preparation of medicines for preventing or treating gastric cancer. The lncRNA-RP11-290F20.3 of the present invention is highly expressed in human gastric cancer tissues and gastric cancer cell lines, and the small interfering RNA of lncRNA-RP11-290F20.3 has the function of inhibiting the proliferation, invasion and migration of gastric cancer cells. Therefore, the lncRNA The small interfering RNA of ‑RP11‑290F20.3 can be used as a new type of drug target, which is of great clinical significance for the prevention and treatment of gastric cancer.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to an application of lncRNA-RP11-290F20.3 and its small interfering RNA or a product using the same. Background technique [0002] Gastric cancer is a common disease that threatens human health. The mortality rate of gastric cancer is very high worldwide, about 14.3 / 100,000 for men and 6.9 / 100,000 for women. Gastric cancer is a malignant tumor derived from gastric mucosal epithelium, accounting for the third of all malignant tumors and the first of digestive tract malignant tumors, accounting for 95% of gastric malignant tumors. The incidence of gastric cancer has obvious geographical differences: the highest in East Asia, Eastern Europe and South America, and the lowest in northern and southern Africa. The incidence of gastric cancer in China is highest in Northwest China, followed by Northeast China and Inner Mongolia, next in East China and coastal areas, and lowest in Centr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68C12N15/113A61K48/00A61K31/7088A61P35/00
CPCC12Q1/6886A61K31/7088C12N15/1135C12N2310/141C12Q2600/118C12Q2600/158C12Q2600/178
Inventor 王建勋林志娟李培峰周志侠
Owner QINGDAO UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com